Credit Suisse’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.17M | Hold |
|
|||||
|
2023
Q4 | $1.37M | Sell |
|
|||||
|
2023
Q3 | $1.64M | Sell |
|
|||||
|
2023
Q2 | $1.99M | Buy |
|
|||||
|
2023
Q1 | $2.18M | Buy |
|
|||||
|
2022
Q4 | $2.9M | Buy |
|
|||||
|
2022
Q3 | $3.14M | Buy |
|
|||||
|
2022
Q2 | $2.61M | Sell |
|
|||||
|
2022
Q1 | $4.19M | Buy |
|
|||||
|
2021
Q4 | $3.38M | Sell |
|
|||||
|
2021
Q3 | $10.7M | Buy |
|
|||||
|
2021
Q2 | $11.3M | Buy |
|
|||||
|
2021
Q1 | $2.4M | Sell |
|
|||||
|
2020
Q4 | $3.02M | Sell |
|
|||||
|
2020
Q3 | $4.4M | Buy |
|
|||||
|
2020
Q2 | $3.65M | Sell |
|
|||||
|
2020
Q1 | $1.75M | Sell |
|
|||||
|
2019
Q4 | $5.53M | Buy |
|
|||||
|
2019
Q3 | $3.36M | Buy |
|
|||||
|
2019
Q2 | $560K | Sell |
|
|||||
|
2019
Q1 | $1.39M | Buy |
|
|||||
|
2018
Q4 | $804K | Buy |
|
|||||
|
2018
Q3 | $296K | Sell |
|
|||||
|
2018
Q2 | $358K | Sell |
|
|||||
|
2018
Q1 | $411K | Buy |
|
|||||
|
2017
Q4 | $342K | Sell |
|
|||||
|
2017
Q3 | $505K | Sell |
|
|||||
|
2017
Q2 | $590K | Sell |
|
|||||
|
2017
Q1 | $931K | Buy |
|
|||||
|
2016
Q4 | $409K | Sell |
|
|||||
|
2016
Q3 | $492K | Sell |
|
|||||
|
2016
Q2 | $367K | Buy |
|
|||||
|
2016
Q1 | $242K | Buy |
|
|||||
|
2015
Q4 | $593K | Sell |
|
|||||
|
2015
Q3 | $734K | Sell |
|
|||||
|
2015
Q2 | $2.74M | Buy |
|
|||||
|
2015
Q1 | $645K | Buy |
|
|||||
|
2014
Q4 | $819K | Sell |
|
|||||
|
2014
Q3 | $666K | Buy |
|
|||||
|
2014
Q2 | $683K | Sell |
|
|||||
|
2014
Q1 | $1.48M | Buy |
|
|||||
|
2013
Q4 | $1.04M | Buy |
|
|||||
|
2013
Q3 | $100K | Sell |
|
|||||
|
2013
Q2 | $111K | Buy |
|